|
Aclaris Therapeutics upgraded to Outperform from Market Perform at SVB Leerink SVB Leerink analyst Pasha Sarraf upgraded Aclaris Therapeutics to Outperform from Market Perform with a $3.50 price target. Read more at: https://thefly.com/landingPageNews.php?id=2978522 |
|
| aus der Diskussion: | Aclaris Therapeutics (ACRS) - Marktkap: $43 M - Reboundplay |
| Autor (Datum des Eintrages): | Biohero (22.10.19 12:58:03) |
| Beitrag: | 1,009 von 2,342 (ID:61742824) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |